Regulatory B cell: New member of immunosuppressive cell club

Human Immunology

Volumn 76, Issue 9, 2015, Pages 615-621

  Ding, Tingting ^a,b,c   Yan, Fan ^a,b,c   Cao, Shui ^a,b,c   Ren, Xiubao ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^c National Cancer Center   (China)

Author keywords

B cell based therapy; Immuno suppressive environment; Regulatory B cells; Tumor immunology

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; GRB PROTEIN; INTERLEUKIN 10; PROTEIN; TUMOR EVOKED BREGS; UNCLASSIFIED DRUG; CYTOKINE; MEMBRANE ANTIGEN;

B LYMPHOCYTE; BREAST CANCER; CELL THERAPY; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TUMOR IMMUNOLOGY; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; METABOLISM; NEOPLASMS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, SURFACE; B-LYMPHOCYTES, REGULATORY; CELL DIFFERENTIATION; CYTOKINES; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOMODULATION; IMMUNOTHERAPY; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84944392614     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.09.006     Document Type: Review

References (84)

1. Morris A., Moller G. Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol. 1968, 101:439-445.
2. Wolf S.D., Dittel B.N., Hardardottir F., Janeway J.C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 1996, 184:2271-2278.
3. Mizoguchi A., Mizoguchi E., Smith R.N., Preffer F.I., Bhan A.K. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 1997, 186:1749-1756.
4. Mizoguchi E., Mizoguchi A., Preffer F.I., Bhan A.K. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 2000, 12:597-605.
5. Yang M., Deng J., Liu Y., Ko K.H., Wang X., Jiao Z., et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am. J. Pathol. 2012, 180:2375-2385.
6. Cantaert T., Doorenspleet M.E., Francosalinas G., Paramarta J.E., Klarenbeek P.L., Tiersma Y., et al. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. Arthritis Rheum. 2012, 64:1859-1868.
7. Scapini P., Lamagna C., Hu Y., Lee K., Tang Q., DeFranco A.L., et al. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E823-32.
8. Liu Y., Chen Y., Li Z., Han Y., Sun Y., Wang Q., et al. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Eur. J. Immunol. 2013, 43:2907-2918.
9. Lee K.M., Kim J.I., Stott R., Soohoo J., O'Connor M.R., Yeh H., et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am. J. Transplant. 2012, 12:2072-2078.
10. Silva H.M., Takenaka M.C., Moraes-Vieira P.M., Monteiro S.M., Hernandez M.O., Chaara W., et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol. Med. 2012, 18:733-743.
11. Biragyn A., Lee-Chang C., Bodogai M. Generation and identification of tumor-evoked regulatory B cells. Methods Mol. Biol. 2014, 1190:271-289.
12. Dong H.P., Elstrand M.B., Holth A., Silins I., Berner A., Trope C.G., et al. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am. J. Clin. Pathol. 2006, 125:451-458.
13. Inoue S., Leitner W.W., Golding B., Scott D. Inhibitory effects of B cells on antitumor immunity. Cancer Res. 2006, 66:7741-7747.
14. Olkhanud P.B., Damdinsuren B., Bodogai M., Gress R.E., Sen R., Wejksza K., et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Res. 2011, 71:3505-3515.
15. Kalampokis I., Yoshizaki A., Tedder T.F. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 2013, 15(Suppl 1):S1.
16. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
17. Das A., Ellis G., Pallant C., Lopes A.R., Khanna P., Peppa D., et al. IL-10-Producing regulatory b cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012, 189:3925-3935.
18. Flores-Borja F., Bosma A., Ng D., Reddy V., Ehrenstein M.R., Isenberg D.A., et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013, 5:123r-173r.
19. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
20. Li X., Zhong H., Bao W., Boulad N., Evangelista J., Haider M.A., et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 2012, 120:3318-3325.
21. Iwata Y., Matsushita T., Horikawa M., Dilillo D.J., Yanaba K., Venturi G.M., et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117:530-541.
22. de Masson A., Bouaziz J.D., Le Buanec H., Robin M., O'Meara A., Parquet N., et al. CD24(hi)CD27(+) and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood 2015, 125:1830-1839.
23. van der Vlugt L.E., Mlejnek E., Ozir-Fazalalikhan A., Janssen B.M., Dijksman T.R., Labuda L.A., et al. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin. Exp. Allergy 2014, 44:517-528.
24. Zha B., Wang L., Liu X., Liu J., Chen Z., Xu J., et al. Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease. PLoS ONE 2012, 7:e49835.
25. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002, 16:219-230.
26. Kessel A., Haj T., Peri R., Snir A., Melamed D., Sabo E., et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 2012, 11:670-677.
27. Noh J., Choi W.S., Noh G., Lee J.H. Presence of foxp3-expressing CD19(+)CD5(+) b cells in human peripheral blood mononuclear cells: Human CD19(+)CD5(+)Foxp3(+) regulatory b cell (Breg). Immun. Netw. 2010, 10:247-249.
28. Noh J., Noh G., Kim H.S., Kim A.R., Choi W.S. Allergen-specific responses of CD19(+)CD5(+)Foxp3(+) regulatory B cells (Bregs) and CD4(+)Foxp3(+) regulatory T cell (Tregs) in immune tolerance of cow milk allergy of late eczematous reactions. Cell. Immunol. 2012, 274:109-114.
29. van de Veen W., Stanic B., Yaman G., Wawrzyniak M., Sollner S., Akdis D.G., et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J. Allergy Clin. Immunol. 2013, 131:1204-1212.
30. Matsushita T., Tedder T.F. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol. Biol. 2011, 677:99-111.
31. Ding Q., Yeung M., Camirand G., Zeng Q., Akiba H., Yagita H., et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 2011, 121:3645-3656.
32. Xiao S., Brooks C.R., Zhu C., Wu C., Sweere J.M., Petecka S., et al. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc. Natl. Acad. Sci. 2012, 109:12105-12110.
33. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
34. Shimabukuro-Vornhagen A., Schlosser H.A., Gryschok L., Malcher J., Wennhold K., Garcia-Marquez M., et al. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget 2014, 5:4651-4664.
35. Lindner S., Dahlke K., Sontheimer K., Hagn M., Kaltenmeier C., Barth T.F., et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013, 73:2468-2479.
36. Mauri C., Bosma A. Immune regulatory function of B cells. Annu. Rev. Immunol. 2012, 30:221-241.
37. Petro J.B., Gerstein R.M., Lowe J., Carter R.S., Shinners N., Khan W.N. Transitional type 1 and 2 b lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 2002, 277:48009-48019.
38. Su T.T., Guo B., Wei B., Braun J., Rawlings D.J. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 2004, 197:161-178.
39. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderon G.E., Sweenie C.H., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008, 180:4763-4773.
40. Poe J.C., Smith S.H., Haas K.M., Yanaba K., Tsubata T., Matsushita T., et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 2011, 6:e22464.
41. Stanic B., van de Veen W., Wirz O.F., Ruckert B., Morita H., Sollner S., et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J. Allergy Clin. Immunol. 2015, 135:771-780.
42. Booth J., Jimbo S., Mutwiri G. Novel B regs down-regulate TLR9-induced cytokine responses in sheep Peyer's patches. Vet. Immunol. Immunopathol. 2012, 148:157-160.
43. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 2004, 172:5986-5993.
44. Berthelot J., Jamin C., Amrouche K., Le Goff B., Maugars Y., Youinou P. Regulatory B cells play a key role in immune system balance. Joint Bone Spine 2013, 80:18-22.
45. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 2003, 197:489-501.
46. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002, 3:944-950.
47. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 2007, 178:7868-7878.
48. hi b cells maintain regulatory t cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013, 5:123r-173r.
49. Bouaziz J.D., Calbo S., Maho-Vaillant M., Saussine A., Bagot M., Bensussan A., et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 2010, 40:2686-2691.
50. Wilde B., Thewissen M., Damoiseaux J., Knippenberg S., Hilhorst M., van Paassen P., et al. Regulatory B cells in ANCA-associated vasculitis. Ann. Rheum. Dis. 2013, 72:1416-1419.
51. Bao W., Zhong H., Manwani D., Vasovic L., Uehlinger J., Lee M.T., et al. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am. J. Hematol. 2013, 88:736-740.
52. Matsumoto M., Fujii Y., Baba A., Hikida M., Kurosaki T., Baba Y. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011, 34:703-714.
53. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009, 182:7459-7472.
54. Yoshizaki A., Miyagaki T., DiLillo D.J., Matsushita T., Horikawa M., Kountikov E.I., et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012, 491:264-268.
55. Yang X., Yang J., Chu Y., Wang J., Guan M., Zhu X., et al. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice. PLoS ONE 2013, 8:e62855.
56. Natarajan P., Singh A., McNamara J.T., Secor E.J., Guernsey L.A., Thrall R.S., et al. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-beta, and co-localize with CD4+Foxp3+ T cells. Mucosal Immunol. 2012, 5:691-701.
57. Ray A., Basu S., Williams C.B., Salzman N.H., Dittel B.N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 2012, 188:3188-3198.
58. Klinker M.W., Lundy S.K. Multiple mechanisms of immune suppression by B lymphocytes. Mol. Med. 2012, 18:123-137.
59. Singh A., Carson W.T., Secor E.J., Guernsey L.A., Flavell R.A., Clark R.B., et al. Regulatory role of B cells in a murine model of allergic airway disease. J. Immunol. 2008, 180:7318-7326.
60. Rabinovich G.A. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 1999, 6:711-721.
61. Iga E.Z., Rabinovich G.A., Iglesias M.M., Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J. Leukocyte Biol. 2001, 70:73.
62. Tretter T., Venigalla R.K., Eckstein V., Saffrich R., Sertel S., Ho A.D., et al. Induction of CD4+ T-cell anergy and apoptosis by activated human B cells. Blood 2008, 112:4555-4564.
63. Lemoine S., Morva A., Youinou P., Jamin C. Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 2011, 36:228-238.
64. Morva A., Lemoine S., Achour A., Pers J.O., Youinou P., Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012, 119:106-114.
65. van Olffen R.W., Koning N., van Gisbergen K.P., Wensveen F.M., Hoek R.M., Boon L., et al. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 2009, 182:7490-7500.
66. Nocentini G., Riccardi C. GITR: a modulator of immune response and inflammation. Adv. Exp. Med. Biol. 2009, 647:156-173.
67. Milne K., Kobel M., Kalloger S.E., Barnes R.O., Gao D., Gilks C.B., et al. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE 2009, 4:e6412.
68. Schioppa T., Moore R., Thompson R.G., Rosser E.C., Kulbe H., Nedospasov S., et al. B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10662-10667.
69. Tadmor T., Zhang Y., Cho H.M., Podack E.R., Rosenblatt J.D. The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol. Immunother. 2011, 60:609-619.
70. Wejksza K., Lee-Chang C., Bodogai M., Bonzo J., Gonzalez F.J., Lehrmann E., et al. Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor alpha. J. Immunol. 2013, 190:2575-2584.
71. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
72. Rousalova I., Krepela E. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int. J. Oncol. 2010, 37:1361-1378.
73. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., Noelle R.J. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 2005, 174:1783-1786.
74. Wieckowski E., Wang G.Q., Gastman B.R., Goldstein L.A., Rabinowich H. Granzyme B-mediated degradation of T-cell receptor zeta chain. Cancer Res. 2002, 62:4884-4889.
75. Shao Y., Lo C.M., Ling C.C., Liu X.B., Ng K.T., Chu A.C., et al. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett. 2014, 355:264-272.
76. Carter N.A., Vasconcellos R., Rosser E.C., Tulone C., Munoz-Suano A., Kamanaka M., et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 2011, 186:5569-5579.
77. Ren X., Akiyoshi K., Dziennis S., Vandenbark A.A., Herson P.S., Hurn P.D., et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 2011, 31:8556-8563.
78. Le Huu D., Matsushita T., Jin G., Hamaguchi Y., Hasegawa M., Takehara K., et al. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013, 121:3274-3283.
79. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011, 34:2026-2032.
80. Giannoukakis N., Trucco M. A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 2012, 19:279-287.
81. Holan V., Zajicova A., Javorkova E., Trosan P., Chudickova M., Pavlikova M., et al. Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells. Immunology 2014, 141:577-586.
82. Lee-Chang C., Bodogai M., Martin-Montalvo A., Wejksza K., Sanghvi M., Moaddel R., et al. Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. J. Immunol. 2013, 191:4141-4151.
83. Bodogai M., Lee C.C., Wejksza K., Lai J., Merino M., Wersto R.P., et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res. 2013, 73:2127-2138.
84. Kim S., Fridlender Z.G., Dunn R., Kehry M.R., Kapoor V., Blouin A., et al. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. J. Immunother. 2008, 31:446-457.